1. Home
  2. SYF vs BNTX Comparison

SYF vs BNTX Comparison

Compare SYF & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Synchrony Financial

SYF

Synchrony Financial

N/A

Current Price

$71.80

Market Cap

24.5B

Sector

Finance

ML Signal

N/A

Logo BioNTech SE

BNTX

BioNTech SE

N/A

Current Price

$87.63

Market Cap

22.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SYF
BNTX
Founded
1932
2008
Country
United States
Germany
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.5B
22.9B
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
SYF
BNTX
Price
$71.80
$87.63
Analyst Decision
Buy
Buy
Analyst Count
23
21
Target Price
$87.00
★ $113.50
AVG Volume (30 Days)
★ 4.3M
1.0M
Earning Date
10-20-2026
11-03-2026
Dividend Yield
★ 1.90%
N/A
EPS Growth
★ 8.54
N/A
EPS
★ 7.52
N/A
Revenue
N/A
N/A
Revenue This Year
$1.17
N/A
Revenue Next Year
$5.11
$0.50
P/E Ratio
$9.56
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$63.08
$79.81
52 Week High
$88.77
$124.00

Technical Indicators

Market Signals
Indicator
SYF
BNTX
Relative Strength Index (RSI) 40.67 43.58
Support Level $69.23 $87.06
Resistance Level $75.01 $93.48
Average True Range (ATR) 2.28 2.62
MACD -0.37 0.26
Stochastic Oscillator 25.60 38.96

Price Performance

Historical Comparison
SYF
BNTX

About SYF Synchrony Financial

Synchrony Financial, originally a spinoff of GE Capital's retail financing business, is the largest provider of private-label credit cards in the United States by both outstanding receivables and purchasing volume. Synchrony partners with other firms to market its credit products in their physical stores as well as on their websites and mobile applications. Synchrony operates through three segments: retail card (private-label and co-branded general-purpose credit cards), payment solutions (promotional financing for large ticket purchases), and CareCredit (financing for elective healthcare procedures).

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: